Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

276studies shown

Showing 1-25 of 276

RecruitingNCT07031661

A Cohort Study of Disease Prediction Model for High-risk Population With Bipolarity

This study is recruiting. It focuses on bipolarity and currently lists participation information in China.

BipolarityOtherFrom 6 Years to 18 Years

Countries: China
Sponsor: Shanghai Mental Health Center
Condition: Bipolarity

View study

RecruitingNCT06508450

A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

DepressionOtherFrom 18 Years to 34 Years

Countries: United States
Sponsor: New York University
Condition: Depression

View study

RecruitingNCT05537376

A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness

This study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.

BipolarityOtherOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Bipolarity

View study

RecruitingNCT07172516

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Depression in bipolarity)

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

DepressionOtherFrom 18 Years to 74 Years

Countries: United States
Sponsor: Xenon Pharmaceuticals Inc.
Condition: Depression

View study

RecruitingNCT03423680

A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Depression in bipolarity

This study is recruiting. It focuses on depression and currently lists participation information in South Korea.

DepressionOtherFrom 19 Years to 70 Years

Countries: South Korea
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Condition: Depression

View study

RecruitingNCT07286175

A Study of Brenipatide in Adult Participants With Bipolarity (RENEW-Bipolar-1)

This study is recruiting. It focuses on bipolarity and currently lists participation information in Argentina, Brazil, China, India, Japan, Mexico, and the United States.

BipolarityOtherFrom 18 Years to 75 Years

Countries: Argentina, Brazil, China, India, Japan, Mexico, United States
Sponsor: Eli Lilly and Company
Condition: Bipolarity

View study

RecruitingNCT07263191

A Study of Olanzapine in Participants With Bipolarity.

This study is recruiting. It focuses on bipolarity and currently lists participation information in South Korea.

BipolarityOtherOver 19 Years

Countries: South Korea
Sponsor: Boryung Pharmaceutical Co., Ltd
Condition: Bipolarity

View study

RecruitingNCT06706687

A Study of the Behavioral Variant of Frontotemporal Dementia and Bipolarity: a Neuroimaging and Epigenetics Integrated Approach

This study is recruiting. It focuses on bipolarity and currently lists participation information in Italy.

BipolarityOtherOver 18 Years

Countries: Italy
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Condition: Bipolarity

View study

RecruitingNCT06657430

A Study on the Preference of Risperidone Dosage Forms

This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.

SchizophreniaOtherOver 18 Years

Countries: China
Sponsor: Shanghai Mental Health Center
Condition: Schizophrenia

View study

RecruitingNCT06696755

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

This study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.

BipolarityOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: AbbVie
Condition: Bipolarity

View study

RecruitingNCT04777357

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolarity I.

This study is recruiting. It focuses on depression and currently lists participation information in the United States and Russian Federation.

DepressionOtherFrom 10 Years to 17 Years

Countries: United States, Russian Federation
Sponsor: AbbVie
Condition: Depression

View study

RecruitingNCT06929273

A Study to Assess the Long-term Safety of KarXT for the Treatment of manic episodes in Bipolarity type I (BALSAM-3)

This study is recruiting. It focuses on bipolarity and currently lists participation information in Argentina, Australia, Bulgaria, China, Croatia, Denmark, France, Hungary, India, Israel, Italy, Japan, New Zealand, Poland, Romania, Slovakia, Spain, Sweden, Ukraine, and the United States.

BipolarityOtherFrom 18 Years to 65 Years

Countries: Argentina, Australia, Bulgaria, China, Croatia, Denmark, France, Hungary, India, Israel, Italy, Japan, New Zealand, Poland, Romania, Slovakia, Spain, Sweden, Ukraine, United States
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

View study

RecruitingNCT07105111

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

SchizophreniaOtherOver 18 Years

Countries: United States
Sponsor: Neurocrine Biosciences
Condition: Schizophrenia

View study

RecruitingNCT07140913

A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolarity type I Taking Lithium, Valproate, or Lamotrigine

This study is recruiting. It focuses on bipolarity and currently lists participation information in Argentina, Bulgaria, China, Denmark, France, India, Israel, Italy, Japan, Poland, Romania, Ukraine, and the United States.

BipolarityOtherFrom 18 Years to 65 Years

Countries: Argentina, Bulgaria, China, Denmark, France, India, Israel, Italy, Japan, Poland, Romania, Ukraine, United States
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

View study

RecruitingNCT06951698

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of manic episodes in Bipolarity type I

This study is recruiting. It focuses on bipolarity and currently lists participation information in Argentina, Australia, Bulgaria, Hungary, Japan, New Zealand, Poland, and the United States.

BipolarityOtherFrom 18 Years to 65 Years

Countries: Argentina, Australia, Bulgaria, Hungary, Japan, New Zealand, Poland, United States
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

View study

RecruitingNCT06951711

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of manic episodes in Bipolarity type I (BALSAM-2)

This study is recruiting. It focuses on bipolarity and currently lists participation information in Croatia, India, Israel, Italy, Romania, Slovakia, Spain, Sweden, Ukraine, and the United States.

BipolarityOtherFrom 18 Years to 65 Years

Countries: Croatia, India, Israel, Italy, Romania, Slovakia, Spain, Sweden, Ukraine, United States
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

View study

RecruitingNCT06365021

ACT for Syndromic and Subsyndromic Depression in Bipolarity

This study is recruiting. It focuses on depression and currently lists participation information in Brazil.

DepressionOtherFrom 18 Years to 65 Years

Countries: Brazil
Sponsor: Beny Lafer
Condition: Depression

View study

RecruitingNCT06656416

ALTO-100 in Bipolarity With Depression (BD-D)

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

DepressionOtherFrom 18 Years to 70 Years

Countries: United States
Sponsor: Alto Neuroscience
Condition: Depression

View study

RecruitingNCT05849402

Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolarity II

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

DepressionOtherFrom 18 Years to 80 Years

Countries: United States
Sponsor: Stanford University
Condition: Depression

View study

RecruitingNCT06706232

Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolarity II Depression and Suicidality

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

DepressionOtherFrom 25 Years to 70 Years

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston
Condition: Depression

View study

RecruitingNCT05491538

Acceptability and Feasibility of Work-Oriented Social-Cognitive Skills Training for Veterans With Serious Mental Illness

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

DepressionOtherOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: Depression

View study

RecruitingNCT05838274

Acute Alcohol Response In Bipolarity: a Longitudinal Alcohol Administration/fMRI Study

This study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.

BipolarityOtherFrom 21 Years to 26 Years

Countries: United States
Sponsor: University of Texas at Austin
Condition: Bipolarity

View study

RecruitingNCT03522545

Adjunctive Allogeneic Mesenchymal Stem Cells for Treatment-resistant Depression in bipolarity

This study is recruiting. It focuses on depression and currently lists participation information in the United States.

DepressionOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: The University of Texas Health Science Center, Houston
Condition: Depression

View study

RecruitingNCT07288320

An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolarity I With Current Mania

This study is recruiting. It focuses on bipolarity and currently lists participation information in the United States.

BipolarityOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Neurocrine Biosciences
Condition: Bipolarity

View study

RecruitingNCT06408012

An Innovative Master Platform for Clinical Trials in Mood Disorders

This study is recruiting. It focuses on depression and currently lists participation information in Canada.

DepressionOtherOver 16 Years

Countries: Canada
Sponsor: St. Joseph's Healthcare Hamilton
Condition: Depression

View study